GL1X · GenesisL1 explorer

MolNFT v1 · #56415 · protein

Structure of the roc domain from the PARKINSON'S disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase

2ZEJ: “Structure of the roc domain from the PARKINSON'S disease-associated leucine-rich repeat kinase 2 reveals a…”. X-ray diffraction, 2 ligands (GDP, MG), 2 pockets (best druggability 0.42). MolNFT v1 #56415 on GenesisL1: 3D structure…

PDB
2ZEJ
Type
protein
Length
319 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Leucine-rich repeat kinase 2
EC
2.7.11.1
UniProt
Q17RV3
Ligands
GDP, MG
Pockets
2 · best druggability 0.42

Structure

x-ray diffraction · 2 distinct chains · 45% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALeucine-rich repeat kinase 2 (EC 2.7.11.1)protein15745% helix, 26% strandQ17RV3
BLeucine-rich repeat kinase 2 (EC 2.7.11.1)protein16245% helix, 26% strandQ17RV3

Ligands and binding sites

  • GDP · Guanosine-5'-diphosphate · ligand · 2 copies · chains A, B
  • MG · Magnesium ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11380.420.7520empty
2880.330.7417empty

Interfaces

1 interface between chains.

  • A–B · 3115 Ų buried · 37 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 12 modified (engineered).

Compared structures

  • 2ZEJ · Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.